Viewing Study NCT02187003


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-06 @ 2:04 PM
Study NCT ID: NCT02187003
Status: COMPLETED
Last Update Posted: 2025-03-11
First Post: 2014-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Sponsor: Biossil Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: B5201002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View